DFSC

OTTAWA, ON, Aug. 18, 2026 /CNW/ -- DEFSEC Technologies Inc. (TSXV:DFSC) (TSXV:DFSC) (NASDAQ:DFSC) (NASDAQ:DFSCW) ("DEFSEC" or the "Company") today announced the closing of its previously announced private placement (the "Offering") for the issuance and sale of 1,951,219 common shares in the capital of the Company, no par value per share (each a "Common Share") (or pre-funded warrants (each a "Pre-funded Warrant") in lieu thereof), at a purchase price of CAD$2.84 (US$2.05) per Common Share (or Pre-funded Warrant in lieu thereof) and Common Share purchase warrants to purchase up to an aggregate of 1,951,219 Common Shares (each a "Common Warrant"). Each Common Warrant is immediately exercisable

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

OTTAWA, ON, Aug. 17, 2026 /CNW/ -- DEFSEC Technologies Inc. (TSXV:DFSC) (TSXV:DFSC) (NASDAQ:DFSC) (NASDAQ:DFSCW) ("DEFSEC" or the "Company") today announced that it has entered into definitive agreements for the issuance and sale of 1,951,219 common shares in the capital of the Company, no par value per share (each a "Common Share") (or pre-funded warrants (each, a "Pre-funded Warrant") in lieu thereof), at a purchase price of CAD$2.84 (US$2.05) per Common Share (or Pre-funded Warrant in lieu therof) and Common Share purchase warrants to purchase up to an aggregate of 1,951,219 Common Shares (each a "Common Warrant") in a private placement (the "Offering"). Each Common Warrant will be immedi

DENVER, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The small-cap market is heating up as earnings acceleration, AI adoption, defense technology and government opportunities create a fresh wave of catalysts. CorMedix Therapeutics: DefenCath Keeps the Cash Flow Story Accelerating CorMedix Therapeutics (NASDAQ:CRMD) is entering the second half of 2026 with increasingly powerful commercial momentum. The company reported $101.9 million in second-quarter consolidated revenue, including $66.1 million from DefenCath and $35.8 million from its acquired Melinta portfolio. Net income reached $26.0 million, while adjusted EBITDA surged to $58.7 million. CorMedix also finished June with $256.7 million in cash

SCHEDULE 13G/A - DEFSEC Technologies Inc. (0001889823) (Subject)

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

Revenue from digitization services on Government programs up 121% from Q3 Fiscal 2025, with total revenue up 92% over the same period;Gross margin $ increase of 126%, with improvement in gross margin to 33.1% from 28.2% in Q3 Fiscal 2025;Strong cash and AR position of +$5.8 million; andTest and Evaluation of BLISS™ completed with U.S. Army Vehicle Program and invitation to an additional invitation-only U.S. Army-Hosted Evaluation for a separate program.OTTAWA, ON, Aug. 13, 2026 /CNW/ -- DEFSEC Technologies Inc. (TSXV:DFSC) (TSXV:DFSC) (NASDAQ:DFSC) (NASDAQ:DFSCW) ("DEFSEC" or the "Company") is pleased to announce the highlights of its Fiscal 2026 third quarter ("Q3 Fiscal 2026") results. Thi

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

EFFECT - DEFSEC Technologies Inc. (0001889823) (Filer)

F-1 - DEFSEC Technologies Inc. (0001889823) (Filer)

D - DEFSEC Technologies Inc. (0001889823) (Filer)

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

OTTAWA, ON, June 26, 2026 /CNW/ - DEFSEC Technologies Inc. (TSXV:DFSC) (TSXV:DFSC) (NASDAQ:DFSC) (NASDAQ:DFSCW) ("DEFSEC" or the "Company"), today announced the closing of its previously announced registered direct offering for the purchase and sale of 673,006 common shares at a purchase price of CAD$3.74 (US$2.63) per common share . In a concurrent private placement, the Company issued unregistered warrants to purchase up to 673,006 common shares at an exercise price of CAD$4.39 per share that are immediately exercisable upon issuance and will expire five years following the date of issuance.

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

424B5 - DEFSEC Technologies Inc. (0001889823) (Filer)

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

OTTAWA, ON, June 25, 2026 /PRNewswire/ - DEFSEC Technologies Inc. (TSXV:DFSC) (TSXV:DFSC) (NASDAQ:DFSC) (NASDAQ:DFSCW) ("DEFSEC" or the "Company"), today announced that it has entered into definitive agreements for the purchase and sale of 673,006 common shares at a purchase price of CAD$3.74 (US$2.63) per common share in a registered direct offering. In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 673,006 common shares at an exercise price of CAD$4.39 per share that will be immediately exercisable upon issuance and will expire five years following the date of issuance. The closing of the offering is expected to occur on or about June 26, 202

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

 Fiscal 2026 Results and Achievement of Significant Product Milestones Revenue on Government programs up 81% from Q2 Fiscal 2025, with total revenue up 68% over the period; Gross margin % up 19% over Fiscal 2025;Defense program billings on an annualized go-forward basis reach approximately $9.41 million;Commercial launch of ARWEN® 40mm baton ammunition;First shipment of PARA SHOTTM system to Public Safety customer; andStrong cash and AR position of +$5 million.OTTAWA, ON, May 13, 2026 /CNW/ - DEFSEC Technologies Inc. (TSXV:DFSC) and (TSXV:DFSC); (NASDAQ:DFSC) and (NASDAQ:DFSCW) ("DEFSEC" or the "Company") is pleased to announce the highlights of its Fiscal 2026 second quarter ("Q2 Fiscal 202

SCHEDULE 13G - DEFSEC Technologies Inc. (0001889823) (Subject)

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

OTTAWA, ON, April 29, 2026 /CNW/ - DEFSEC Technologies Inc. (TSXV:DFSC) (TSXV:DFSC) (NASDAQ:DFSC) (NASDAQ:DFSCW) ("DEFSEC" or the "Company") today confirmed that it has now shipped two new networked BLISSTM systems to the United States Army Yuma Test Center (US Army YTC) for test and evaluation. The BLISSTM shipment today to the US Army YTC follows delivery of an earlier version, called BLDS (Battlefield Laser Detection System) to the U.S. Army last year for testing and trial activity.  BLISSTM is an enhanced, networked version of BLDS as the next step in the evolution of the Co

6-K - DEFSEC Technologies Inc. (0001889823) (Filer)

David Ibbetson, Former General Manager of General Dynamics Mission Systems International joins boardPaul Mangano retires from the BoardOTTAWA, ON, April 20, 2026 /CNW/ - DEFSEC Technologies Inc. (TSXV:DFSC) (TSXV:DFSC) (NASDAQ:DFSC) (NASDAQ:DFSCW) ("DEFSEC" or the "Company") today announced that David Ibbetson, former General Manager of General Dynamics Mission Systems International ("GDMS") has joined DEFSEC's board of directors.  Mr. Ibbetson has more than 35 years in the Aerospace and Defence Industry, and 25 years with General Dynamics, where he served in progressively senio